Background
Methods
Study population
The questionnaire
Assessments of the GPs
Patient characteristics
N | % | ||
---|---|---|---|
Gender | |||
N = 27313 | Female | 18985 | 69.5 |
Male | 8328 | 30.5 | |
Age (years) | |||
N = 27379 | 18–24 | 1284 | 4.7 |
25–29 | 2296 | 8.4 | |
30–34 | 3060 | 11.2 | |
35–39 | 2872 | 10.5 | |
40–44 | 2392 | 8.7 | |
45–49 | 1988 | 7.3 | |
50–54 | 2169 | 7.9 | |
55–59 | 2376 | 8.7 | |
60–64 | 2109 | 7.7 | |
65–69 | 1945 | 7.1 | |
70–74 | 1813 | 6.6 | |
75–79 | 1551 | 5.7 | |
80+ | 1524 | 5.6 | |
Further education (years) | |||
N = 25870 | None | 4766 | 18.4 |
Less than 2 | 2019 | 7.8 | |
2–4 | 14094 | 54.5 | |
5 or more | 3591 | 13.9 | |
Undergoing education or other | 1400 | 5.4 | |
Frequency of attendance (last 12 months) | |||
N = 25860 | 0–1 | 2434 | 9.4 |
2–3 | 7848 | 30.4 | |
4–5 | 6535 | 25.3 | |
6–7 | 3534 | 13.7 | |
8–9 | 1840 | 7.1 | |
10+ | 3669 | 14.2 | |
Duration of listing with the GP (years) | |||
N = 18134 | Less than 1 | 1431 | 7.9 |
1–2 | 2065 | 11.4 | |
3–7 | 5600 | 30.9 | |
8–12 | 3962 | 21.9 | |
13+ | 5076 | 28.0 | |
Self-rated health
| |||
N = 27087 | Excellent | 2350 | 8.7 |
Very good | 8121 | 30.0 | |
Good | 10488 | 38.7 | |
Fair | 5141 | 19.0 | |
Poor | 987 | 3.6 | |
Chronic condition
| |||
N = 26801 | No | 13703 | 51.1 |
Yes-KRTC1
| 4509 | 16.8 | |
Yes-other or multiple | 8589 | 32.1 | |
Chronic condition
| |||
N = 182122
| None | 13703 | 72.1 |
K – Cardiovascular | 2029 | 10.7 | |
R – Respiratory | 1095 | 5.8 | |
T – Endocrine | 1085 | 5.7 | |
C – Cancer | 300 | 1.6 |
Statistics
Ethical approval
Informed consent
Results
100% positive assessments 1
| 0–49% positive assessments 2
| ||||||||
---|---|---|---|---|---|---|---|---|---|
Prev.(%) | PR | Adj. PR | 95% CI | Prev.(%) | PR | Adj. PR | 95% CI | ||
Gender
| |||||||||
(N = 25533) | Female | 63.8 | 1 | 1 | 14.9 | 1 | 1 | ||
Male | 65.1 | 1.02 | 0.98 | 0.96 – 1.00 | 13.0 |
0.87
| 0.93 | 0.86 – 1.00 | |
Age (years) | |||||||||
(N = 25533) | 18–24 | 52.3 | 1 | 1 | 16.4 | 1 | 1 | ||
25–29 | 54.3 | 1.04 | 1.03 | 0.96 – 1.10 | 16.6 | 1.03 | 1.03 | 0.87 – 1.22 | |
30–34 | 57.6 |
1.10
|
1.10
|
1.04 – 1.18
| 16.7 | 1.00 | 0.99 | 0.86 – 1.15 | |
35–39 | 58.8 |
1.12
|
1.15
|
1.08 – 1.22
| 17.0 | 1.01 | 0.96 | 0.82 – 1.13 | |
40–44 | 60.1 |
1.15
|
1.20
|
1.13 – 1.29
| 17.3 | 1.00 | 0.93 | 0.80 – 1.09 | |
45–49 | 61.2 |
1.17
|
1.23
|
1.15 – 1.32
| 16.1 |
0.90
|
0.83
|
0.70 – 0.98
| |
50–54 | 65.2 |
1.25
|
1.33
|
1.25 – 1.42
| 14.2 |
0.88
|
0.71
|
0.60 – 0.85
| |
55–59 | 67.6 |
1.29
|
1.39
|
1.30 – 1.48
| 13.0 |
0.74
|
0.64
|
0.54 – 0.77
| |
60–64 | 70.2 |
1.34
|
1.43
|
1.35 – 1.53
| 11.8 |
0.67
|
0.58
|
0.48 – 0.70
| |
65–69 | 76.8 |
1.47
|
1.57
|
1.47 – 1.67
| 9.4 |
0.58
|
0.47
|
0.38 – 0.58
| |
70–74 | 76.7 |
1.46
|
1.57
|
1.47 – 1.67
| 10.5 |
0.53
|
0.52
|
0.43 – 0.63
| |
75–79 | 73.6 |
1.41
|
1.52
|
1.43 – 1.63
| 11.2 |
0.51
|
0.55
|
0.44 – 0.67
| |
80+ | 72.8 |
1.39
|
1.50
|
1.40 – 1.61
| 10.4 |
0.57
|
0.49
|
0.39 – 0.62
| |
Further education (years) | |||||||||
(N = 24364) | None | 66.3 | 13
| 13
| 13.3 | 1 | 1 | ||
Less than 2 | 64.5 |
0.94
| 1.01 | 0.97 – 1.05 | 14.8 | 1.12 | 1.05 | 0.92 – 1.19 | |
2–4 | 63.8 |
0.86
| 0.99 | 0.96 – 1.02 | 14.6 | 1.10 | 1.07 | 0.98 – 1.17 | |
5 or more | 62.2 |
0.73
| 0.96 | 0.93 – 1.00 | 14.7 | 1.10 | 1.11 | 0.99 – 1.25 | |
Undergoing education or other | |||||||||
66.0 |
0.91
|
1.06
|
1.01 – 1.10
| 12.4 | 0.94 | 0.91 | 0.76 – 1.08 | ||
Frequency of attendance (times per year) | |||||||||
(N = 25533) | 0–1 | 60.7 | 1 | 1 | 16.4 | 1 | 1 | ||
2–3 | 61.9 | 1.02 | 1.04 | 1.00 – 1.07 | 15.7 | 0.95 | 0.91 | 0.82 – 1.01 | |
4–5 | 64.6 |
1.06
|
1.08
|
1.04 – 1.11
| 14.1 |
0.86
|
0.79
|
0.71 – 0.88
| |
6–7 | 65.1 |
1.07
|
1.10
|
1.05 – 1.14
| 14.1 |
0.86
|
0.74
|
0.66 – 0.84
| |
8–9 | 67.5 |
1.11
|
1.14
|
1.09 – 1.19
| 13.0 |
0.79
|
0.67
|
0.58 – 0.77
| |
10+ | 68.2 |
1.12
|
1.18
|
1.14 – 1.23
| 11.4 |
0.69
|
0.53
|
0.46 – 0.61
| |
Duration of listing (years) | |||||||||
(N = 16985) | Less than 1 | 63.2 | 1 | 1 | 16.5 | 1 | 1 | ||
1–2 | 64.6 | 1.02 | 1.00 | 0.95 – 1.05 | 13.6 |
0.82
| 0.89 | 0.75 – 1.05 | |
3–7 | 64.6 | 1.02 | 0.98 | 0.94 – 1.02 | 13.7 |
0.83
| 0.92 | 0.80 – 1.07 | |
8–12 | 65.5 | 1.04 | 0.97 | 0.92 – 1.02 | 13.4 |
0.81
| 0.93 | 0.80 – 1.08 | |
13+ | 68.3 |
1.08
| 1.00 | 0.95 – 1.05 | 11.9 |
0.72
|
0.85
|
0.73 – 0.99
| |
Self-rated health
| |||||||||
(N = 25533) | Excellent | 67.6 | 1 | 1 | 12.0 | 1 | 1 | ||
Very good | 64.5 |
0.95
|
0.92
|
0.89 – 0.94
| 12.5 | 1.04 |
1.14
|
1.01 – 1.29
| |
Good | 65.0 |
0.96
|
0.83
|
0.81 – 0.86
| 14.6 |
1.22
|
1.66
|
1.46 – 1.87
| |
Fair | 61.4 |
0.91
|
0.74
|
0.72 – 0.77
| 17.2 |
1.44
|
2.29
|
2.01 – 2.62
| |
Poor | 58.2 |
0.86
|
0.69
|
0.65 – 0.74
| 18.6 |
1.56
|
2.66
|
2.21 – 3.20
| |
Chronic condition
| |||||||||
(N = 25170)
| No | 62.3 | 1 | 13
| 14.8 | 1 | 1 | ||
Yes-KRTC | 70.6 |
1.13
|
1.06
|
1.03 – 1.09
| 12.2 |
0.83
|
0.89
|
0.81 – 0.99
| |
Yes-other or multiple | 63.9 | 1.03 |
1.04
|
1.01 – 1.06
| 14.7 | 0.99 |
0.89
|
0.82 – 0.96
| |
Chronic condition
| |||||||||
(N = 17192) | None | 62.3 | 1 | 13
| 14.8 | 1 | 1 | ||
K – Cardiovascular | 72.1 |
1.16
|
1.05
|
1.01 – 1.09
| 10.7 |
0.73
| 0.85 | 0.73 – 1.00 | |
R – Respiratory | 66.5 |
1.07
|
1.06
|
1.01 – 1.11
| 14.9 | 1.01 | 0.99 | 0.85 – 1.15 | |
T – Endocrine | 69.8 |
1.12
| 1.04 | 1.00 – 1.09 | 13.7 | 0.93 | 1.01 | 0.85 – 1.20 | |
C – Cancer | 77.7 |
1.25
|
1.20
|
1.12 – 1.28
| 6.6 |
0.44
|
0.46
|
0.29 – 0.73
|
100% positive assessments 1
| 0–49% positive assessments 2
| ||||||||
---|---|---|---|---|---|---|---|---|---|
Prev.(%) | PR | Adj. PR | 95% CI | Prev.(%) | PR | Adj. PR | 95% CI | ||
Gender
| |||||||||
(N = 25377) | Female | 61.2 | 1 | 13
| 19.4 | 1 | 1 | ||
Male | 61.2 | 1.00 |
0.95
|
0.93 – 0.97
| 19.2 | 0.99 | 1.06 | 1.00 – 1.13 | |
Age (years) | |||||||||
(N = 25377) | 18–24 | 47.8 | 1 | 13
| 26.2 | 1 | 1 | ||
25–29 | 52.3 |
1.09
| 1.07 | 0.99 – 1.16 | 23.2 | 1.03 | 0.92 | 0.82 – 1.04 | |
30–34 | 56.8 |
1.19
|
1.18
|
1.10 – 1.26
| 21.6 | 1.00 |
0.84
|
0.75 – 0.93
| |
35–39 | 56.3 |
1.18
|
1.20
|
1.13 – 1.29
| 21.8 | 1.01 |
0.79
|
0.71 – 0.88
| |
40–44 | 57.7 |
1.21
|
1.29
|
1.19 – 1.38
| 20.9 | 1.00 |
0.71
|
0.63 – 0.79
| |
45–49 | 57.5 |
1.20
|
1.31
|
1.22 – 1.41
| 21.9 |
0.90
|
0.70
|
0.62 – 0.78
| |
50–54 | 61.1 |
1.28
|
1.44
|
1.33 – 1.55
| 19.0 |
0.88
|
0.57
|
0.50 – 0.65
| |
55–59 | 64.5 |
1.35
|
1.55
|
1.43 – 1.66
| 17.9 |
0.74
|
0.52
|
0.46 – 0.60
| |
60–64 | 67.1 |
1.40
|
1.61
|
1.50 – 1.73
| 15.6 |
0.67
|
0.45
|
0.40 – 0.52
| |
65–69 | 73.0 |
1.53
|
1.76
|
1.64 – 1.88
| 13.1 |
0.58
|
0.38
|
0.33 – 0.45
| |
70–74 | 71.4 |
1.49
|
1.73
|
1.61 – 1.86
| 14.9 |
0.53
|
0.43
|
0.38 – 0.50
| |
75–79 | 70.1 |
1.47
|
1.73
|
1.61 – 1.85
| 14.8 |
0.51
|
0.42
|
0.36 – 0.48
| |
80+ | 69.8 |
1.46
|
1.73
|
1.60 – 1.87
| 15.6 |
0.57
|
0.42
|
0.36 – 0.50
| |
Further education (years) | |||||||||
(N = 24220) | None | 60.2 | 1 | 13
| 19.6 | 1 | 1 | ||
Less than 2 | 60.4 | 1.01 | 1.03 | 0.99 – 1.07 | 20.8 | 1.06 | 1.04 | 0.94 – 1.16 | |
2–4 | 61.5 | 0.91 | 1.02 | 0.99 – 1.05 | 19.1 | 0.97 | 1.02 | 0.95 – 1.10 | |
5 or more | 61.2 | 0.80 | 1.00 | 0.97 – 1.04 | 18.8 | 0.96 | 1.03 | 0.93 – 1.14 | |
Undergoing education or other | 61.4 | 0.90 |
1.07
|
1.02 – 1.12
| 17.3 | 0.88 |
0.85
|
0.74 – 0.97
| |
Frequency of attendance (times per year) | |||||||||
(N = 25377) | 0–1 | 64.2 | 1 | 13
| 19.0 | 1 | 1 | ||
2–3 | 60.9 |
0.95
| 0.98 | 0.95 – 1.01 | 19.2 | 1.01 | 0.96 | 0.88 – 1.05 | |
4–5 | 61.9 | 0.96 | 1.01 | 0.98 – 1.05 | 19.3 | 1.02 | 0.92 | 0.84 – 1.01 | |
6–7 | 60.0 |
0.94
| 1.01 | 0.98 – 1.06 | 19.3 | 1.02 |
0.85
|
0.77 – 0.94
| |
8–9 | 60.6 |
0.94
| 1.04 | 1.00 – 1.09 | 19.5 | 1.03 |
0.82
|
0.73 – 0.92
| |
10+ | 60.1 |
0.94
|
1.09
|
1.04 – 1.14
| 19.8 | 1.04 |
0.74
|
0.67 – 0.83
| |
Duration of listing (years) | |||||||||
(N = 16880) | Less than 1 | 60.5 | 1 | 13
| 20.3 | 1 | 1 | ||
1–2 | 62.7 | 1.04 | 1.01 | 0.96 – 1.07 | 18.4 | 0.91 | 0.99 | 0.86 – 1.12 | |
3–7 | 61.2 | 1.01 | 0.96 | 0.91 – 1.01 | 19.0 | 0.93 | 1.05 | 0.93 – 1.18 | |
8–12 | 62.4 | 1.03 | 0.96 | 0.90 – 1.01 | 19.1 | 0.94 | 1.11 | 0.98 – 1.27 | |
13+ | 65.8 |
1.09
| 1.00 | 0.94 – 1.06 | 16.0 |
0.79
| 0.94 | 0.83 – 1.08 | |
Self-rated health
| |||||||||
(N = 25377) | Excellent | 71.8 | 1 | 13
| 13.4 | 1 | 1 | ||
Very good | 64.8 |
0.90
|
0.86
|
0.83 – 0.89
| 15.7 |
1.17
|
1.27
|
1.14 – 1.43
| |
Good | 61.1 |
0.85
|
0.72
|
0.70 – 0.75
| 19.2 |
1.43
|
1.90
|
1.69 – 2.13
| |
Fair | 52.4 |
0.73
|
0.59
|
0.56 – 0.61
| 26.5 |
1.97
|
2.94
|
2.60 – 3.31
| |
Poor | 48.2 |
0.67
|
0.53
|
0.49 – 0.58
| 30.2 |
2.25
|
3.43
|
2.96 – 3.97
| |
Chronic condition
| |||||||||
(N = 25017) | No | 64.6 | 1 | 13
| 18.6 | 1 | 1 | ||
Yes-KRTC | 67.9 |
1.10
|
1.09
|
1.06 – 1.12
| 15.9 |
0.86
|
0.84
|
0.77 – 0.92
| |
Yes-other or multiple | 57.1 |
0.93
| 1.01 | 0.98 – 1.04 | 22.2 |
1.19
| 0.96 | 0.90 – 1.02 | |
Chronic condition
| |||||||||
(N = 17058) | 61.6 | 1 | 13
| 18.6 | 1 | 1 | |||
K – Cardiovascular | 70.6 |
1.15
|
1.12
|
1.08 – 1.16
| 13.7 |
0.73
|
0.76
|
0.67 – 0.87
| |
R – Respiratory | 60.6 | 0.98 | 1.05 | 0.99 – 1.10 | 19.4 | 1.04 | 0.90 | 0.79 – 1.04 | |
T – Endocrine | 68.2 |
1.11
|
1.11
|
1.06 – 1.16
| 17.9 | 0.96 | 0.94 | 0.81 – 1.08 | |
C – Cancer | 75.2 |
1.22
|
1.28
|
1.19 – 1.37
| 11.7 |
0.63
|
0.55
|
0.39 – 0.77
|
100% positive assessments 1
| 0–49% positive assessments 2
| ||||||||
---|---|---|---|---|---|---|---|---|---|
Prev.(%) | PR | Adj. PR | 95% CI | Prev.(%) | PR | Adj. PR | 95% CI | ||
Gender
| |||||||||
(N = 25154) | Female | 64.5 | 1 | 13
| 19.7 | 1 | 1 | ||
Male | 64.4 | 1.00 |
0.95
|
0.93 – 0.97
| 19.1 | 0.97 | 1.05 | 0.99 – 1.11 | |
Age (years) | |||||||||
(N = 25154) | 18–24 | 52.4 | 1 | 13
| 25.0 | 1 | 1 | ||
25–29 | 55.5 | 1.06 | 1.04 | 0.97 – 1.12 | 23.7 | 1.03 | 0.96 | 0.84 – 1.10 | |
30–34 | 57.8 |
1.10
|
1.10
|
1.03 – 1.18
| 22.9 | 1.00 | 0.90 | 0.79 – 1.02 | |
35–39 | 60.2 |
1.15
|
1.18
|
1.11 – 1.26
| 22.5 | 1.01 |
0.84
|
0.74 – 0.94
| |
40–44 | 61.0 |
1.16
|
1.23
|
1.15 – 1.32
| 22.6 | 1.00 |
0.79
|
0.70 – 0.90
| |
45–49 | 62.1 |
1.19
|
1.28
|
1.19 – 1.37
| 21.1 |
0.90
|
0.71
|
0.61 – 0.81
| |
50–54 | 63.9 |
1.22
|
1.34
|
1.26 – 1.43
| 18.8 |
0.88
|
0.61
|
0.53 – 0.70
| |
55–59 | 68.8 |
1.31
|
1.47
|
1.37 – 1.57
| 17.2 |
0.74
|
0.54
|
0.47 – 0.63
| |
60–64 | 70.9 |
1.35
|
1.52
|
1.42 – 1.62
| 16.2 |
0.67
|
0.51
|
0.44 – 0.59
| |
65–69 | 75.1 |
1.43
|
1.61
|
1.50 – 1.72
| 13.1 |
0.58
|
0.41
|
0.35 – 0.49
| |
70–74 | 75.6 |
1.44
|
1.62
|
1.52 – 1.73
| 14.4 |
0.53
|
0.46
|
0.39 – 0.54
| |
75–79 | 71.7 |
1.37
|
1.56
|
1.45 – 1.67
| 15.1 |
0.51
|
0.47
|
0.40 – 0.56
| |
80+ | 73.7 |
1.41
|
1.61
|
1.50 – 1.72
| 14.2 |
0.57
|
0.43
|
0.36 – 0.51
| |
Further education (years) | |||||||||
(N = 24003) | None | 65.9 | 1 | 13
| 19.1 | 1 | 1 | ||
Less than 2 | 65.1 |
0.95
| 1.02 | 0.98 – 1.06 | 20.6 | 1.08 | 1.03 | 0.92 – 1.15 | |
2–4 | 64.1 |
0.85
| 0.99 | 0.96 – 1.01 | 19.5 | 1.02 | 1.01 | 0.93 – 1.08 | |
5 or more | 63.5 |
0.73
| 0.97 | 0.94 – 1.01 | 19.4 | 1.01 | 1.01 | 0.92 – 1.11 | |
Undergoing education or other | 63.9 |
0.84
| 1.02 | 0.97 – 1.07 | 18.7 | 0.97 | 0.91 | 0.79 – 1.06 | |
Frequency of attendance (times per year) | |||||||||
(N = 25154) | 0–1 | 63.9 | 1 | 13
| 22.5 | 1 | 1 | ||
2–3 | 63.1 | 0.99 | 1.01 | 0.98 – 1.05 | 20.8 | 0.93 |
0.89
|
0.81 – 0.98
| |
4–5 | 63.8 | 1.00 | 1.03 | 1.00 – 1.07 | 18.9 |
0.84
|
0.79
|
0.71 – 0.86
| |
6–7 | 65.7 | 1.03 |
1.09
|
1.05 – 1.13
| 19.4 |
0.86
|
0.75
|
0.68 – 0.83
| |
8–9 | 66.0 | 1.03 |
1.11
|
1.06 – 1.16
| 18.5 |
0.82
|
0.70
|
0.62 – 0.79
| |
10+ | 66.6 | 1.04 |
1.17
|
1.12 – 1.22
| 16.5 |
0.73
|
0.57
|
0.51 – 0.63
| |
Duration of listing (years) | |||||||||
(N = 16745) | Less than 1 | 63.9 | 1 | 13
| 20.2 | 1 | 1 | ||
1–2 | 65.4 | 1.02 | 0.99 | 0.94 – 1.05 | 18.8 | 0.93 | 1.01 | 0.88 – 1.17 | |
3–7 | 65.0 | 1.02 | 0.97 | 0.92 – 1.01 | 18.5 | 0.91 | 1.02 | 0.90 – 1.16 | |
8–12 | 66.0 | 1.03 | 0.96 | 0.91 – 1.01 | 18.2 | 0.90 | 1.05 | 0.91 – 1.21 | |
13+ | 68.2 |
1.07
| 0.98 | 0.93 – 1.03 | 17.0 |
0.84
| 1.01 | 0.88 – 1.16 | |
Self-rated health
| |||||||||
(N = 25154) | Excellent | 71.2 | 1 | 13
| 15.7 | 1 | 1 | ||
Very good | 66.9 |
0.94
|
0.89
|
0.87 – 0.92
| 17.2 | 1.10 |
1.21
|
1.09 – 1.35
| |
Good | 64.5 |
0.91
|
0.77
|
0.75 – 0.80
| 19.7 |
1.26
|
1.72
|
1.55 – 1.91
| |
Fair | 58.8 |
0.83
|
0.66
|
0.63 – 0.68
| 23.4 |
1.50
|
2.38
|
2.12 – 2.68
| |
Poor | 55.8 |
0.78
|
0.62
|
0.58 – 0.66
| 26.5 |
1.69
|
2.82
|
2.42 – 3.29
| |
Chronic condition
| |||||||||
(N = 24795) | No | 63.7 | 1 | 13
| 20.2 | 1 | 1 | ||
Yes-KRTC | 70.9 |
1.11
|
1.07
|
1.05 – 1.10
| 15.5 |
0.77
|
0.82
|
0.75 – 0.89
| |
Yes-other or multiple | 62.1 | 0.98 | 1.02 | 0.99 – 1.04 | 20.6 | 1.02 |
0.90
|
0.85 – 0.97
| |
Chronic condition
| |||||||||
(N = 16860) | None | 63.7 | 1 | 13
| 20.2 | 1 | 1 | ||
K – Cardiovascular | 73.0 |
1.15
|
1.09
|
1.05 – 1.13
| 14.3 |
0.71
|
0.80
|
0.71 – 0.91
| |
R – Respiratory | 65.5 | 1.03 |
1.06
|
1.01 – 1.11
| 19.5 | 0.97 | 0.91 | 0.79 – 1.04 | |
T – Endocrine | 70.7 |
1.11
|
1.08
|
1.03 – 1.13
| 15.0 |
0.74
|
0.79
|
0.68 – 0.92
| |
C – Cancer | 76.8 |
1.21
|
1.21
|
1.13 – 1.31
| 11.1 |
0.55
|
0.53
|
0.37 – 0.75
|
100% positive assessments 1
| 0–49% positive assessments 2
| ||||||||
---|---|---|---|---|---|---|---|---|---|
Prev.(%) | PR | Adj. PR | 95% CI | Prev.(%) | PR | Adj. PR | 95% CI | ||
Gender
| |||||||||
(N = 24154) | Female | 64.5 | 1 | 13
| 23.4 | 1 | 1 | ||
Male | 68.3 |
1.06
| 1.01 | 0.99 – 1.03 |
19.4
|
0.83
|
0.91
|
0.85 – 0.96
| |
Age (years) | |||||||||
(N = 24154) | 18–24 | 58.4 | 1 | 13
| 28.1 | 1 | 1 | ||
25–29 | 55.8 | 0.96 | 0.95 | 0.89 – 1.01 | 28.9 | 1.03 | 1.04 | 0.93 – 1.17 | |
30–34 | 58.6 | 1.00 | 1.00 | 0.95 – 1.07 | 27.0 | 1.00 | 0.94 | 0.84 – 1.05 | |
35–39 | 60.0 | 1.03 | 1.05 | 0.99 – 1.11 | 25.2 | 1.01 |
0.85
|
0.76 – 0.95
| |
40–44 | 62.0 | 1.06 |
1.11
|
1.04 – 1.18
| 24.3 | 1.00 |
0.78
|
0.69 – 0.89
| |
45–49 | 61.8 | 1.06 |
1.12
|
1.05 – 1.19
| 25.3 |
0.90
|
0.80
|
0.70 – 0.91
| |
50–54 | 65.5 |
1.12
|
1.20
|
1.13 – 1.28
| 22.2 |
0.88
|
0.68
|
0.60 – 0.78
| |
55–59 | 68.7 |
1.18
|
1.27
|
1.20 – 1.35
| 20.3 |
0.74
|
0.62
|
0.55 – 0.70
| |
60–64 | 71.6 |
1.23
|
1.33
|
1.25 – 1.41
| 18.0 |
0.67
|
0.55
|
0.48 – 0.64
| |
65–69 | 76.3 |
1.31
|
1.42
|
1.34 – 1.50
| 14.9 |
0.58
|
0.46
|
0.39 – 0.53
| |
70–74 | 77.7 |
1.33
|
1.44
|
1.36 – 1.53
| 14.9 |
0.53
|
0.46
|
0.39 – 0.55
| |
75–79 | 76.1 |
1.30
|
1.43
|
1.34 – 1.52
| 14.5 |
0.51
|
0.44
|
0.37 – 0.52
| |
80+ | 76.5 |
1.31
|
1.44
|
1.36 – 1.54
| 16.3 |
0.57
|
0.48
|
0.41 – 0.57
| |
Further education (years) | |||||||||
(N = 23058) | None | 68.5 | 1 | 1 | 20.4 | 1 | 1 | ||
Less than 2 | 65.1 |
0.96
| 1.00 | 0.96 – 1.03 | 22.2 | 1.09 | 1.00 | 0.90 – 1.11 | |
2–4 | 64.6 |
0.84
| 0.97 | 0.95 – 1.00 | 22.8 |
1.12
| 1.07 | 0.99 – 1.15 | |
5 or more | 64.8 |
0.79
| 0.98 | 0.95 – 1.01 | 23.0 |
1.13
| 1.11 | 1.00 – 1.22 | |
Undergoing education or other | 67.8 |
0.85
|
1.05
|
1.01 – 1.10
| 20.5 | 1.00 | 0.94 | 0.81 – 1.08 | |
Frequency of attendance (times per year) | |||||||||
(N = 24154) | 0–1 | 66.1 | 1 | 13
| 24.3 | 1 | 1 | ||
2–3 | 64.3 | 0.97 | 0.99 | 0.96 – 1.03 | 24.4 | 1.00 | 0.96 | 0.88 – 1.05 | |
4–5 | 65.1 | 0.98 | 1.01 | 0.97 – 1.04 | 22.5 | 0.93 |
0.87
|
0.80 – 0.95
| |
6–7 | 65.7 | 0.99 | 1.04 | 1.00 – 1.08 | 21.2 |
0.87
|
0.78
|
0.70 – 0.86
| |
8–9 | 68.0 | 1.03 |
1.08
|
1.03 – 1.13
| 19.4 |
0.80
|
0.70
|
0.62 – 0.80
| |
10+ | 68.2 | 1.03 |
1.12
|
1.08 – 1.17
| 18.7 |
0.77
|
0.63
|
0.57 – 0.69
| |
Duration of listing (years) | |||||||||
(N = 16168) | Less than 1 | 65.6 | 1 | 13
| 25.8 | 1 | 1 | ||
1–2 | 64.8 | 0.99 | 0.97 | 0.92 – 1.02 | 23.8 | 0.92 | 0.97 | 0.86 – 1.10 | |
3–7 | 65.6 | 1.00 | 0.96 | 0.92 – 1.01 | 21.9 |
0.85
| 0.92 | 0.82 – 1.04 | |
8–12 | 68.1 | 1.04 | 0.98 | 0.93 – 1.03 | 20.2 |
0.78
| 0.89 | 0.78 – 1.01 | |
13+ | 70.7 |
1.08
| 1.00 | 0.95 – 1.05 | 17.5 |
0.68
|
0.79
|
0.69 – 0.90
| |
Self-rated health
| |||||||||
(N = 24154) | Excellent | 70.0 | 1 | 13
| 19.6 | 1 | 1 | ||
Very good | 67.1 |
0.96
|
0.92
|
0.89 – 0.95
| 21.2 | 1.08 |
1.18
|
1.07 – 1.30
| |
Good | 66.3 |
0.95
|
0.82
|
0.79 – 0.84
| 21.8 |
1.11
|
1.51
|
1.37 – 1.65
| |
Fair | 61.1 |
0.87
|
0.71
|
0.69 – 0.74
| 25.3 |
1.29
|
2.02
|
1.82 – 2.24
| |
Poor | 60.8 |
0.87
|
0.70
|
0.65 – 0.74
| 25.1 |
1.28
|
2.11
|
1.82 – 2.44
| |
Chronic condition
| |||||||||
(N = 23810) | No | 64.9 | 1 | 13
| 23.4 | 1 | 1 | ||
Yes-KRTC | 71.2 |
1.10
|
1.03
|
1.01 – 1.06
| 17.9 |
0.77
|
0.88
|
0.81 – 0.96
| |
Yes-other or multiple | 63.8 | 0.98 | 1.00 | 0.98 – 1.03 | 22.7 | 0.97 | 0.93 | 0.88 – 1.00 | |
Chronic condition
| |||||||||
(N = 16049) | None | 64.9 | 1 | 13
| 23.4 | 1 | 1 | ||
K – Cardiovascular | 66.3 |
1.14
|
1.05
|
1.01 – 1.09
| 19.8 |
0.68
|
0.85
|
0.76 – 0.96
| |
R – Respiratory | 73.8 | 1.02 | 1.02 | 0.97 – 1.07 | 16.0 | 0.95 | 0.96 | 0.85 – 1.09 | |
T – Endocrine | 66.2 |
1.09
| 1.03 | 0.99 – 1.08 | 22.1 | 0.81 | 0.92 | 0.80 – 1.07 | |
C – Cancer | 70.5 |
1.16
|
1.12
|
1.04 – 1.21
| 18.8 | 0.56 |
0.62
|
0.46 – 0.84
|
100% positive assessments 1
| 0–49% positive assessments 2
| ||||||||
---|---|---|---|---|---|---|---|---|---|
Prev.(%) | PR | Adj. PR | 95% CI | Prev.(%) | PR | Adj.PR | 95% CI | ||
Gender
| |||||||||
(N = 25560) | Female | 29.1 | 1 | 1 | 34.0 | 1 | 1 | ||
Male | 32.3 |
1.11
| 0.97 | 0.93 – 1.02 | 30.7 |
0.90
| 0.99 | 0.94 – 1.03 | |
Age (years) | |||||||||
(N = 25560) | 18–24 | 17.8 | 1 | 1 | 39.5 | 1 | 1 | ||
25–29 | 19.7 | 1.11 | 1.09 | 0.94 – 1.26 | 40.7 | 1.03 | 1.04 | 0.96 – 1.13 | |
30–34 | 21.0 |
1.18
|
1.19
|
1.03 – 1.37
| 39.4 | 1.00 | 0.98 | 0.90 – 1.07 | |
35–39 | 21.5 |
1.21
|
1.25
|
1.09 – 1.44
| 40.0 | 1.01 | 0.97 | 0.89 – 1.06 | |
40–44 | 23.6 |
1.32
|
1.42
|
1.23 – 1.64
| 39.5 | 1.00 | 0.93 | 0.85 – 1.02 | |
45–49 | 26.5 |
1.49
|
1.62
|
1.41 – 1.87
| 35.7 |
0.90
|
0.83
|
0.76 – 0.91
| |
50–54 | 27.9 |
1.57
|
1.75
|
1.52 – 2.01
| 35.0 |
0.88
|
0.80
|
0.73 – 0.88
| |
55–59 | 34.3 |
1.92
|
2.17
|
1.90 – 2.48
| 29.4 |
0.74
|
0.67
|
0.61 – 0.75
| |
60–64 | 38.5 |
2.16
|
2.44
|
2.12 – 2.80
| 26.5 |
0.67
|
0.60
|
0.54 – 0.67
| |
65–69 | 42.6 |
2.39
|
2.72
|
2.37 – 3.12
| 22.9 |
0.58
|
0.53
|
0.46 – 0.59
| |
70–74 | 46.7 |
2.62
|
2.99
|
2.61 – 3.42
| 20.8 |
0.53
|
0.48
|
0.42 – 0.54
| |
75–79 | 46.5 |
2.61
|
2.97
|
2.60 – 3.39
| 20.2 |
0.51
|
0.46
|
0.40 – 0.53
| |
80+ | 45.7 |
2.56
|
2.96
|
2.57 – 3.41
| 22.4 |
0.57
|
0.51
|
0.45 – 0.57
| |
Further education (years) | |||||||||
(N = 24385) | None | 32.6 | 1 | 1 | 31.7 | 1 | 1 | ||
Less than 2 | 30.6 |
0.90
| 1.08 | 0.99 – 1.16 | 34.7 |
1.09
| 1.00 | 0.93 – 1.08 | |
2–4 | 28.6 |
0.76
| 1.00 | 0.95 – 1.06 | 34.1 |
1.08
| 0.98 | 0.93 – 1.03 | |
5 or more | 29.3 |
0.66
| 1.02 | 0.94 – 1.10 | 32.1 | 1.01 | 0.93 | 0.86 – 1.01 | |
Undergoing education or other | 32.2 |
0.80
|
1.16
|
1.06 – 1.27
| 28.8 | 0.91 |
0.83
|
0.75 – 0.91
| |
Frequency of attendance (times per year) | |||||||||
(N = 25560) | 0–1 | 28.3 | 1 | 1 | 35.9 | 1 | 1 | ||
2–3 | 26.9 | 0.95 | 0.99 | 0.92 – 1.07 | 37.0 | 1.03 | 1.00 | 0.94 – 1.06 | |
4–5 | 29.8 | 1.05 | 1.06 | 0.98 – 1.14 | 33.5 |
0.93
|
0.92
|
0.86 – 0.98
| |
6–7 | 31.4 |
1.11
|
1.14
|
1.04 – 1.24
| 30.0 |
0.84
|
0.81
|
0.75 – 0.87
| |
8–9 | 33.9 |
1.20
|
1.21
|
1.11 – 1.33
| 28.5 |
0.79
|
0.77
|
0.70 – 0.84
| |
10+ | 35.3 |
1.25
|
1.30
|
1.20 – 1.42
| 26.8 |
0.75
|
0.69
|
0.64 – 0.75
| |
Duration of listing (years) | |||||||||
(N = 17001) | Less than 1 | 24.6 | 1 | 1 | 36.8 | 1 | 1 | ||
1–2 | 25.9 | 1.05 | 0.99 | 0.87 – 1.12 | 36.1 | 0.98 | 1.03 | 0.94 – 1.12 | |
3–7 | 27.2 | 1.11 | 1.00 | 0.89 – 1.12 | 34.7 | 0.94 | 1.01 | 0.93 – 1.09 | |
8–12 | 31.8 |
1.29
| 1.12 | 0.98 – 1.28 | 31.6 |
0.86
| 0.95 | 0.86 – 1.05 | |
13+ | 38.0 |
1.55
|
1.29
|
1.13 – 1.48
| 26.5 |
0.72
|
0.82
|
0.73 – 0.92
| |
Self-rated health
| |||||||||
(N = 25560) | Excellent | 30.6 | 1 | 1 | 30.1 | 1 | 1 | ||
Very good | 28.6 | 0.93 |
0.83
|
0.78 – 0.89
| 33.6 |
1.11
|
1.19
|
1.11 – 1.28
| |
Good | 30.6 | 1.00 |
0.68
|
0.64 – 0.73
| 33.4 |
1.11
|
1.44
|
1.34 – 1.54
| |
Fair | 30.7 | 1.00 |
0.60
|
0.55 – 0.65
| 33.3 |
1.11
|
1.64
|
1.51 – 1.78
| |
Poor | 33.0 | 1.08 |
0.62
|
0.56 – 0.70
| 29.2 | 0.97 |
1.49
|
1.31 – 1.69
| |
Chronic condition
| |||||||||
(N = 25197) | No | 27.6 | 1 | 1 | 35.2 | 1 | 1 | ||
Yes-KRTC | 36.6 |
1.33
| 1.04 | 0.98 – 1.10 | 27.9 |
0.79
| 0.97 | 0.91 – 1.03 | |
Yes-other or multiple | 30.5 |
1.10
| 1.01 | 0.96 – 1.06 | 32.1 |
0.91
| 0.95 | 0.91 – 1.00 | |
Chronic condition
| |||||||||
(N = 17208) | None | 27.6 | 1 | 1 | 35.2 | 1 | 1 | ||
K – Cardiovascular | 37.7 |
1.37
| 1.01 | 0.94 – 1.09 | 26.1 |
0.74
| 0.96 | 0.86 – 1.06 | |
R – Respiratory | 32.3 |
1.17
| 1.04 | 0.95 – 1.15 | 31.8 | 0.90 | 0.99 | 0.90 – 1.09 | |
T – Endocrine | 37.0 |
1.34
| 1.08 | 0.99 – 1.17 | 28.9 |
0.82
| 0.98 | 0.88 – 1.09 | |
C – Cancer | 42.7 |
1.55
|
1.15
|
1.01 – 1.32
| 22.3 |
0.63
|
0.78
|
0.61 – 0.98
|